The Rivaroxaban Market size continues to expand due to rising cases of cardiovascular and thromboembolic disorders worldwide. Increasing patient awareness, innovative drug formulations, and favorable regulatory frameworks are key factors driving market growth. The adoption of oral anticoagulants over traditional therapies enhances patient compliance and clinical outcomes, which...